$200.00
Rinvoq® (upadacitinib) 15 mg Tablets – Bottle of 30 Tablets
Product Description:
Rinvoq® is a prescription medication that contains upadacitinib, a Janus kinase (JAK) inhibitor used to treat moderate to severe rheumatoid arthritis, atopic dermatitis, and ulcerative colitis in adults. By selectively inhibiting the Janus kinase (JAK) enzymes, Rinvoq works to reduce inflammation and prevent tissue damage caused by overactive immune responses. Rinvoq helps manage chronic inflammatory conditions by modulating the immune system, offering effective symptom relief and improving overall patient function. It is suitable for patients who have not responded well to other treatments, including biologic therapies.
Product Features:
Active Ingredient: Upadacitinib
Strength: 15 mg per tablet
Dosage Form: Oral tablet
Quantity: Bottle of 30 tablets
Administration: Taken once daily, with or without food
Indications:
Moderate to severe rheumatoid arthritis: Treatment of adult patients with moderate to severe rheumatoid arthritis who have had an inadequate response or are intolerant to methotrexate
Moderate to severe atopic dermatitis (eczema): Used to treat moderate to severe atopic dermatitis in adults who are candidates for systemic therapy
Moderate to severe ulcerative colitis: Treatment of moderate to severe ulcerative colitis in adults who have not responded well to or cannot tolerate conventional therapies
Other inflammatory conditions: May be used for additional inflammatory conditions under healthcare provider guidance
Reviews
There are no reviews yet.